Description

Neotranex solution for injections 500 mg/5 ml. ampoules №5

Ingredients:

Neotranex solution for injections contains 500 mg of the active ingredient per 5 ml ampoule.

Dosage:

The recommended dosage of Neotranex solution for injections is determined by a healthcare provider based on the patient’s condition and response to treatment.

Indications:

Neotranex solution for injections is indicated for the treatment of certain medical conditions where tranexamic acid is beneficial.

Contraindications:

Do not use Neotranex solution for injections if you have a known allergy to tranexamic acid or any other ingredients in the formulation.

Directions:

Neotranex solution for injections is administered by a healthcare professional through intravenous injection. Follow all instructions provided by your healthcare provider.

Scientific Evidence:

Studies have shown that tranexamic acid, the active ingredient in Neotranex solution for injections, is effective in reducing blood loss during surgical procedures and in the treatment of certain bleeding disorders. Research published in the Journal of Trauma and Acute Care Surgery demonstrated the efficacy of tranexamic acid in trauma patients.

Additional Information:

It is important to inform your healthcare provider about any medications you are currently taking before using Neotranex solution for injections to avoid potential drug interactions. Always store the ampoules in a cool, dry place away from direct sunlight.

Neotranex solution for injections works by inhibiting the breakdown of blood clots, thereby reducing bleeding. This pharmacological action makes it particularly useful in surgeries, dental procedures, and certain medical conditions characterized by excessive bleeding.

Compared to other antifibrinolytic agents, Neotranex has shown comparable efficacy with a favorable safety profile. Clinical trials have demonstrated its effectiveness in reducing blood loss and transfusion requirements in various surgical settings.